✦ LIBER ✦

Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients

✍ Scribed by Rony M. Abou-Jawde; Janice Reed; Megan Kelly; Esteban Walker; Steven Andresen; Rachid Baz; Mary Ann Karam; Mohamad Hussein

Book ID: 111641078
Publisher: Springer US
Year: 2006
Tongue: English
Weight: 172 KB
Volume: 23
Category: Article
ISSN: 1357-0560
DOI: 10.1385/mo:23:2:263

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of melphalan, arsenic trioxide,

Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma

✍ Borad, M J; Swift, R; Berenson, J R 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Efficacy and safety of melphalan, arseni

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study

✍ James R. Berenson; Ralph Boccia; David Siegel; Marek Bozdech; Alberto Bessudo; E 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

A Prospective, Open-Label Safety and Eff

A Prospective, Open-Label Safety and Efficacy Study of Combination Treatment with Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients with Relapsed or Refractory Multiple Myeloma

✍ Berenson, James R.; Swift, Regina A.; Ferretti, Delina; Purner, Matthew B. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 99 KB

Safety and efficacy of a combination the

Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience

✍ Tommaso Caravita; Agostina Siniscalchi; Andrea Tendas; Luca Cupelli; Micaela Ale 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 60 KB

A phase 2 trial of combination therapy w

A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)

✍ Nelli Bejanyan; Ramon V. Tiu; Azra Raza; Ania Jankowska; Matt Kalaycio; Anjali A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

The efficacy and safety of lenalidomide

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

✍ Meletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views